_id
6919e45f3c536f8df231808e
Ticker
AOTI.LSE
Name
AOTI Inc
Exchange
LSE
Address
3512 Seagate Way, Oceanside, CA, United States, 92056
Country
UK
Sector
Healthcare
Industry
Medical Devices
Currency
GBX
Website
https://aotinc.net
Description
AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.
Last Close
315000
Volume
112410
Current Price
29.8
Change
-20.476190476190474
Last Updated
2025-12-29T14:59:10.522Z
Image
https://logo.clearbit.com/aotinc.net
Ipo Date
-
Market Cap
36653136
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2024-12-31
Revenue
5603549
Cost Of Revenue
2462123
Gross Profit
3141425
Operating Expenses
2451333
Operating Income
690092
Interest Expense
134582
Pretax Income
486382
Net Income
369402
Eps
0.0034731563278661754
Dividends Per Share
-
Shares Outstanding
116359163
Income Tax Expense
116980
EBITDA
783581
Operating Margin
12.315266628345714
Total Other Income Expense Net
-203710
Cash
9336000
Short Term Investments
-
Receivables
14817000
Inventories
2514000
Total Current Assets
26684000
Property Plant Equipment
3815000
Total Assets
39540000
Payables
1550000
Short Term Debt
189000
Long Term Debt
-
Total Liabilities
22099000
Equity
17441000
Bs_currency_symbol
-
Depreciation
162618
Change In Working Capital
-1302355
Cash From Operations
-662876
Capital Expenditures
243113
Cash From Investing
-216582
Cash From Financing
-796471
Net Change In Cash
-1645219
Cf_currency_symbol
-
PE
15.75
PB
181.72714049653115
ROE
2.118009288458231
ROA
0.9342488619119879
FCF
-905989
Fcf Percent
-0.16168128448595703
Piotroski FScore
2
Health Score
34
Deep Value Investing Score
3
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
3
Quality Investing Score
4
Value Investing Score
4
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
5603549
Quarters > 0 > income Statement > cost Of Revenue
2462123
Quarters > 0 > income Statement > gross Profit
3141425
Quarters > 0 > income Statement > operating Expenses
2451333
Quarters > 0 > income Statement > operating Income
690092
Quarters > 0 > income Statement > interest Expense
134582
Quarters > 0 > income Statement > pretax Income
486382
Quarters > 0 > income Statement > net Income
369402
Quarters > 0 > income Statement > eps
0.0034731563278661754
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
106359163
Quarters > 0 > income Statement > income Tax Expense
116980
Quarters > 0 > income Statement > EBITDA
783581
Quarters > 0 > income Statement > operating Margin
12.315266628345714
Quarters > 0 > income Statement > total Other Income Expense Net
-203710
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
9336000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
14817000
Quarters > 0 > balance Sheet > inventories
2514000
Quarters > 0 > balance Sheet > total Current Assets
26684000
Quarters > 0 > balance Sheet > property Plant Equipment
3815000
Quarters > 0 > balance Sheet > total Assets
39540000
Quarters > 0 > balance Sheet > payables
1550000
Quarters > 0 > balance Sheet > short Term Debt
189000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
22099000
Quarters > 0 > balance Sheet > equity
17441000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
369402
Quarters > 0 > cash Flow > depreciation
162618
Quarters > 0 > cash Flow > change In Working Capital
-1302355
Quarters > 0 > cash Flow > cash From Operations
-662876
Quarters > 0 > cash Flow > capital Expenditures
243113
Quarters > 0 > cash Flow > cash From Investing
-216582
Quarters > 0 > cash Flow > cash From Financing
-796471
Quarters > 0 > cash Flow > net Change In Cash
-1645219
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.0034731563278661754
Quarters > 0 > ratios > PB
181.72714049653115
Quarters > 0 > ratios > ROE
2.118009288458231
Quarters > 0 > ratios > ROA
0.9342488619119879
Quarters > 0 > ratios > FCF
-905989
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.16168128448595703
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
4405358
Quarters > 1 > income Statement > cost Of Revenue
3010425
Quarters > 1 > income Statement > gross Profit
1394933
Quarters > 1 > income Statement > operating Expenses
1844581
Quarters > 1 > income Statement > operating Income
-449651
Quarters > 1 > income Statement > interest Expense
181300
Quarters > 1 > income Statement > pretax Income
-622920
Quarters > 1 > income Statement > net Income
-646761
Quarters > 1 > income Statement > eps
-0.006080912605585601
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
106359200
Quarters > 1 > income Statement > income Tax Expense
23841
Quarters > 1 > income Statement > EBITDA
-307689
Quarters > 1 > income Statement > operating Margin
-10.206911674374705
Quarters > 1 > income Statement > total Other Income Expense Net
-173269
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3312330
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1353413
Quarters > 1 > balance Sheet > inventories
334580
Quarters > 1 > balance Sheet > total Current Assets
5000325
Quarters > 1 > balance Sheet > property Plant Equipment
587133
Quarters > 1 > balance Sheet > total Assets
7128703
Quarters > 1 > balance Sheet > payables
289303
Quarters > 1 > balance Sheet > short Term Debt
47260
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4558009
Quarters > 1 > balance Sheet > equity
2570694
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-646761
Quarters > 1 > cash Flow > depreciation
133932
Quarters > 1 > cash Flow > change In Working Capital
-772099
Quarters > 1 > cash Flow > cash From Operations
-371375
Quarters > 1 > cash Flow > capital Expenditures
96564
Quarters > 1 > cash Flow > cash From Investing
-123093
Quarters > 1 > cash Flow > cash From Financing
3668052
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.006080912605585601
Quarters > 1 > ratios > PB
1232.9371601598634
Quarters > 1 > ratios > ROE
-25.15900375540613
Quarters > 1 > ratios > ROA
-9.072632146408681
Quarters > 1 > ratios > FCF
-467939
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.1062204252185634
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
3948729
Quarters > 2 > income Statement > cost Of Revenue
2208855
Quarters > 2 > income Statement > gross Profit
1739874
Quarters > 2 > income Statement > operating Expenses
2472212
Quarters > 2 > income Statement > operating Income
-732339
Quarters > 2 > income Statement > interest Expense
167225
Quarters > 2 > income Statement > pretax Income
-927461
Quarters > 2 > income Statement > net Income
-941469
Quarters > 2 > income Statement > eps
-0.008851790230805031
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
106359163
Quarters > 2 > income Statement > income Tax Expense
14007
Quarters > 2 > income Statement > EBITDA
-631822
Quarters > 2 > income Statement > operating Margin
-18.54619549733598
Quarters > 2 > income Statement > total Other Income Expense Net
-195121
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
778000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5321000
Quarters > 2 > balance Sheet > inventories
2205000
Quarters > 2 > balance Sheet > total Current Assets
8344000
Quarters > 2 > balance Sheet > property Plant Equipment
3288000
Quarters > 2 > balance Sheet > total Assets
21081000
Quarters > 2 > balance Sheet > payables
5789000
Quarters > 2 > balance Sheet > short Term Debt
286000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
26992000
Quarters > 2 > balance Sheet > equity
-5911000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-941469
Quarters > 2 > cash Flow > depreciation
128417
Quarters > 2 > cash Flow > change In Working Capital
705813
Quarters > 2 > cash Flow > cash From Operations
17930
Quarters > 2 > cash Flow > capital Expenditures
113310
Quarters > 2 > cash Flow > cash From Investing
-93743
Quarters > 2 > cash Flow > cash From Financing
-34742
Quarters > 2 > cash Flow > net Change In Cash
-132862
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.008851790230805031
Quarters > 2 > ratios > PB
-536.2042052782947
Quarters > 2 > ratios > ROE
15.927406530197935
Quarters > 2 > ratios > ROA
-4.4659598690764195
Quarters > 2 > ratios > FCF
-95380
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.02415460772314332
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
3790683
Quarters > 3 > income Statement > cost Of Revenue
1973329
Quarters > 3 > income Statement > gross Profit
1817354
Quarters > 3 > income Statement > operating Expenses
2046101
Quarters > 3 > income Statement > operating Income
-228746
Quarters > 3 > income Statement > interest Expense
176918
Quarters > 3 > income Statement > pretax Income
-405664
Quarters > 3 > income Statement > net Income
-488433
Quarters > 3 > income Statement > eps
-0.004592296670151712
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
106359200
Quarters > 3 > income Statement > income Tax Expense
82768
Quarters > 3 > income Statement > EBITDA
-107153
Quarters > 3 > income Statement > operating Margin
-6.0344270412482395
Quarters > 3 > income Statement > total Other Income Expense Net
-176918
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
265678
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
822453
Quarters > 3 > balance Sheet > inventories
328203
Quarters > 3 > balance Sheet > total Current Assets
1416336
Quarters > 3 > balance Sheet > property Plant Equipment
470930
Quarters > 3 > balance Sheet > total Assets
3522400
Quarters > 3 > balance Sheet > payables
246402
Quarters > 3 > balance Sheet > short Term Debt
39615
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3712650
Quarters > 3 > balance Sheet > equity
-190249
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-488433
Quarters > 3 > cash Flow > depreciation
121592
Quarters > 3 > cash Flow > change In Working Capital
-91751
Quarters > 3 > cash Flow > cash From Operations
-311954
Quarters > 3 > cash Flow > capital Expenditures
111745
Quarters > 3 > cash Flow > cash From Investing
-131309
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.004592296670151712
Quarters > 3 > ratios > PB
-16659.76777801723
Quarters > 3 > ratios > ROE
256.7335439345279
Quarters > 3 > ratios > ROA
-13.866483079718373
Quarters > 3 > ratios > FCF
-423699
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.1117737885230709
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
58359000
Annuals > 0 > income Statement > cost Of Revenue
7004000
Annuals > 0 > income Statement > gross Profit
51355000
Annuals > 0 > income Statement > operating Expenses
50100000
Annuals > 0 > income Statement > operating Income
1255000
Annuals > 0 > income Statement > interest Expense
1853000
Annuals > 0 > income Statement > pretax Income
-945000
Annuals > 0 > income Statement > net Income
-1756000
Annuals > 0 > income Statement > eps
-0.01651009607888697
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
106359163
Annuals > 0 > income Statement > income Tax Expense
811000
Annuals > 0 > income Statement > EBITDA
2638000
Annuals > 0 > income Statement > operating Margin
2.1504823591905278
Annuals > 0 > income Statement > total Other Income Expense Net
-2200000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
9336000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
14817000
Annuals > 0 > balance Sheet > inventories
2514000
Annuals > 0 > balance Sheet > total Current Assets
26684000
Annuals > 0 > balance Sheet > property Plant Equipment
3815000
Annuals > 0 > balance Sheet > total Assets
39540000
Annuals > 0 > balance Sheet > payables
1550000
Annuals > 0 > balance Sheet > short Term Debt
189000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
22099000
Annuals > 0 > balance Sheet > equity
17441000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-1756000
Annuals > 0 > cash Flow > depreciation
1730000
Annuals > 0 > cash Flow > change In Working Capital
-11705000
Annuals > 0 > cash Flow > cash From Operations
-5910000
Annuals > 0 > cash Flow > capital Expenditures
1941000
Annuals > 0 > cash Flow > cash From Investing
-1941000
Annuals > 0 > cash Flow > cash From Financing
16409000
Annuals > 0 > cash Flow > net Change In Cash
8558000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.01651009607888697
Annuals > 0 > ratios > PB
195.14323811708044
Annuals > 0 > ratios > ROE
-10.068230032681612
Annuals > 0 > ratios > ROA
-4.4410723318158825
Annuals > 0 > ratios > FCF
-7851000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.13452937850203053
Annuals > 0 > health Score
17
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
43917834
Annuals > 1 > income Statement > cost Of Revenue
6324041
Annuals > 1 > income Statement > gross Profit
37593793
Annuals > 1 > income Statement > operating Expenses
43130408
Annuals > 1 > income Statement > operating Income
-5536615
Annuals > 1 > income Statement > interest Expense
1950087
Annuals > 1 > income Statement > pretax Income
-7649720
Annuals > 1 > income Statement > net Income
-8187210
Annuals > 1 > income Statement > eps
-0.07697697989454604
Annuals > 1 > income Statement > dividends Per Share
1444788
Annuals > 1 > income Statement > shares Outstanding
106359200
Annuals > 1 > income Statement > income Tax Expense
537490
Annuals > 1 > income Statement > EBITDA
-4280589
Annuals > 1 > income Statement > operating Margin
-12.606757883369202
Annuals > 1 > income Statement > total Other Income Expense Net
-2113105
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
778484
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
5321407
Annuals > 1 > balance Sheet > inventories
2203516
Annuals > 1 > balance Sheet > total Current Assets
8343552
Annuals > 1 > balance Sheet > property Plant Equipment
3287863
Annuals > 1 > balance Sheet > total Assets
21080853
Annuals > 1 > balance Sheet > payables
5789137
Annuals > 1 > balance Sheet > short Term Debt
286245
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
26991666
Annuals > 1 > balance Sheet > equity
-5910813
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-8187210
Annuals > 1 > cash Flow > depreciation
1419044
Annuals > 1 > cash Flow > change In Working Capital
3858836
Annuals > 1 > cash Flow > cash From Operations
-1447194
Annuals > 1 > cash Flow > capital Expenditures
1315081
Annuals > 1 > cash Flow > cash From Investing
-1585616
Annuals > 1 > cash Flow > cash From Financing
-202808
Annuals > 1 > cash Flow > net Change In Cash
-3235618
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-0.07697697989454604
Annuals > 1 > ratios > PB
-575.8081671675284
Annuals > 1 > ratios > ROE
138.51241783490698
Annuals > 1 > ratios > ROA
-38.837185573088526
Annuals > 1 > ratios > FCF
-2762275
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.06289643063908844
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
8860757
Annuals > 2 > income Statement > cost Of Revenue
6000192
Annuals > 2 > income Statement > gross Profit
2860565
Annuals > 2 > income Statement > operating Expenses
566684
Annuals > 2 > income Statement > operating Income
2293880
Annuals > 2 > income Statement > interest Expense
1343582
Annuals > 2 > income Statement > pretax Income
2257449
Annuals > 2 > income Statement > net Income
1741403
Annuals > 2 > income Statement > eps
0.016372853554705014
Annuals > 2 > income Statement > dividends Per Share
462856
Annuals > 2 > income Statement > shares Outstanding
106359163
Annuals > 2 > income Statement > income Tax Expense
516045
Annuals > 2 > income Statement > EBITDA
475614
Annuals > 2 > income Statement > operating Margin
25.8880815713601
Annuals > 2 > income Statement > total Other Income Expense Net
-1339404
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
2560717
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4042440
Annuals > 2 > balance Sheet > inventories
274907
Annuals > 2 > balance Sheet > total Current Assets
3646245
Annuals > 2 > balance Sheet > property Plant Equipment
5689603
Annuals > 2 > balance Sheet > total Assets
9349759
Annuals > 2 > balance Sheet > payables
952445
Annuals > 2 > balance Sheet > short Term Debt
381750
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
5936692
Annuals > 2 > balance Sheet > equity
3413066
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
1741403
Annuals > 2 > cash Flow > depreciation
546101
Annuals > 2 > cash Flow > change In Working Capital
-33334
Annuals > 2 > cash Flow > cash From Operations
2770216
Annuals > 2 > cash Flow > capital Expenditures
998939
Annuals > 2 > cash Flow > cash From Investing
-1230822
Annuals > 2 > cash Flow > cash From Financing
648654
Annuals > 2 > cash Flow > net Change In Cash
2340517
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
0.016372853554705014
Annuals > 2 > ratios > PB
997.1952537688986
Annuals > 2 > ratios > ROE
51.02166204814088
Annuals > 2 > ratios > ROA
18.62511108575098
Annuals > 2 > ratios > FCF
1771277
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.1999013176865137
Annuals > 2 > health Score
76
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
889098
Annuals > 3 > income Statement > cost Of Revenue
843739
Annuals > 3 > income Statement > gross Profit
45359
Annuals > 3 > income Statement > operating Expenses
123672
Annuals > 3 > income Statement > operating Income
-78310
Annuals > 3 > income Statement > interest Expense
34242
Annuals > 3 > income Statement > pretax Income
-84515
Annuals > 3 > income Statement > net Income
-86819
Annuals > 3 > income Statement > eps
-0.0008162813391075671
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
106359163
Annuals > 3 > income Statement > income Tax Expense
2303.36
Annuals > 3 > income Statement > EBITDA
3584486
Annuals > 3 > income Statement > operating Margin
-8.807802964352636
Annuals > 3 > income Statement > total Other Income Expense Net
-44304
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
220200
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2418062
Annuals > 3 > balance Sheet > inventories
29407
Annuals > 3 > balance Sheet > total Current Assets
347218
Annuals > 3 > balance Sheet > property Plant Equipment
1160700
Annuals > 3 > balance Sheet > total Assets
1508627
Annuals > 3 > balance Sheet > payables
794384
Annuals > 3 > balance Sheet > short Term Debt
269078
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1250339
Annuals > 3 > balance Sheet > equity
258287
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-86819
Annuals > 3 > cash Flow > depreciation
90539
Annuals > 3 > cash Flow > change In Working Capital
-52091
Annuals > 3 > cash Flow > cash From Operations
-46067
Annuals > 3 > cash Flow > capital Expenditures
382358
Annuals > 3 > cash Flow > cash From Investing
-392103
Annuals > 3 > cash Flow > cash From Financing
490970
Annuals > 3 > cash Flow > net Change In Cash
-1086101
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.0008162813391075671
Annuals > 3 > ratios > PB
13177.175839279562
Annuals > 3 > ratios > ROE
-33.61338356169688
Annuals > 3 > ratios > ROA
-5.7548353569172495
Annuals > 3 > ratios > FCF
-428425
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.4818647663137247
Annuals > 3 > health Score
8
Valuation > metrics > PE
15.75
Valuation > metrics > PB
181.72714049653115
Valuation > final Score
50
Valuation > verdict
2978.8% Overvalued
Profitability > metrics > ROE
2.118009288458231
Profitability > metrics > ROA
1.3843576675161144
Profitability > metrics > Net Margin
0.06592286424192953
Profitability > final Score
18
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.2670718422108824
Risk > metrics > Interest Coverage
5.127669376291035
Risk > final Score
51
Risk > verdict
High
Liquidity > metrics > Current Ratio
15.344450833812536
Liquidity > metrics > Quick Ratio
13.898792409430706
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
32
Prev Profitabilities > 2
40
Prev Risks > 0
20
Prev Risks > 1
12
Prev Risks > 2
25
Prev Liquidities > 0
100
Prev Liquidities > 1
84
Prev Liquidities > 2
100
Updated At
2026-01-20T22:59:47.099Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-22
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-27
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.02
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-16
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.05
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.05
Earnings History > 2 > surprise Percent
-
AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUS technology firm AOTI chooses UK instead of US for record Aim listing MoneyWeek
Read more →(Last Updated 2024-12-31)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2024-12-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of AOTI Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2024-12-31)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.